David Ferreira

Dr. David Ferreira


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2020 in Medical Journal of Australia
Verified
Journal Article
Open access
PDF file
JDJoshua S Davis
Joshua S Davis
DFDavid Ferreira
David Ferreira
JDJustin T Denholm
Justin T Denholm
STSteven Yc Tong
Steven Yc Tong
Since coronavirus disease 2019 (COVID‐19) emerged in Wuhan, China in December 2019 and spread around the world, over 1100 clinical studies have been registered globally on clinical trials registri...

1 September 2024 in European Heart Journal
Verified
Journal Article
Open access
PDF file
DFDavid Ferreira
David Ferreira
JHJack Hardy
Jack Hardy
WMWilliam Meere
William Meere
LBLloyd Butel-Simoes
Lloyd Butel-Simoes
SSShanathan Sritharan
Shanathan Sritharan
BWBradley Wilsmore
Bradley Wilsmore
Background and Aims: Current guidelines recommend 6 h of solid food and 2 h of clear liquid fasting for patients undergoing cardiac procedures with conscious sedation. There are no data to support this practice, and previous single-centre studies support the safety of removing fasting requirements. The objective of this study was to determine the non-inferiority of a no-fasting strategy to fasting prior to cardiac catheterization procedures which require conscious sedation. Methods: This is a multicentre, investigator-initiated, non-inferiority, randomized trial conducted in Australia with a prospective open-label, blinded endpoint design. Patients referred for coronary angiography, percutaneous coronary intervention, or cardiac implantable electronic device (CIED)-related procedures were enrolled. Patients were randomized 1:1 to fasting as normal (6 h solid food and 2 h clear liquid) or no-fasting requirements (encouraged to have regular meals but not mandated to do so). Recruitment occurred from 2022 to 2023. The primary outcome was a composite of aspiration pneumonia, hypotension, hyperglycaemia, and hypoglycaemia assessed with a Bayesian approach. Secondary outcomes included patient satisfaction score, new ventilation requirement (non-invasive and invasive), new intensive care unit admission, 30-day readmission, 30-day mortality, 30-day pneumonia. Results: A total of 716 patients were randomized with 358 in each group. Those in the fasting arm had significantly longer solid food fasting (13.2 vs. 3.0 h, Bayes factor >100, indicating extreme evidence of difference) and clear liquid fasting times (7.0 vs. 2.4 h, Bayes factor >100). The primary composite outcome occurred in 19.1% of patients in the fasting arm and 12.0% of patients in the no-fasting arm. The estimate of the mean posterior difference in proportions with credibility interval (CI) in the primary composite outcome was −5.2% (95% CI −9.6 to −.9), favouring no fasting. This result confirms the non-inferiority (posterior probability >99.5%) and superiority (posterior probability 99.1%) of no fasting for the primary composite outcome. The no-fasting arm had improved patient satisfaction scores with a posterior mean difference of 4.02 points (95% CI 3.36–4.67, Bayes factor >100). Secondary outcome events were observed to be similar. Conclusions: In patients undergoing cardiac catheterization and CIED-related procedures, no fasting was non-inferior and superior to fasting for the primary composite outcome of aspiration pneumonia, hypotension, hyperglycaemia, and hypoglycaemia. Patient satisfaction scores were significantly better with no fasting. This supports removing fasting requirements for patients undergoing cardiac catheterization laboratory procedures that require conscious sedation.

15 December 2018 in Internal Medicine Journal
Verified
Journal Article
Closed access
PDF file
DFDavid Ferreira
David Ferreira
EVEswari Vilayur
Eswari Vilayur
MGMichael Gao
Michael Gao
CSChristy Sankoorikal
Christy Sankoorikal
CBCino Bendinelli
Cino Bendinelli

17 October 2023 in European Heart Journal Open
Verified
Journal Article
Open access
PDF file
DFDavid Ferreira
David Ferreira
JHJack Hardy
Jack Hardy
WMWill Meere
Will Meere
LBLloyd Butel-Simoes
Lloyd Butel-Simoes
MMMichael McGee
Michael McGee
ABAndrew Boyle
Andrew Boyle
Aims: Cardiac catheterization procedures are typically performed with local anaesthetic and proceduralist guided sedation. Various fasting regimens are routinely implemented prior to these procedures, noting the absence of prospective evidence, aiming to reduce aspiration risk. However, there are additional risks from fasting including patient discomfort, intravascular volume depletion, stimulus for neuro-cardiogenic syncope, glycaemic outcomes, and unnecessary fasting for delayed/cancelled procedures. Methods and results: This is an investigator-initiated, multicentre, randomized trial with a prospective, open-label, blinded endpoint (PROBE) assessment based in New South Wales, Australia. Patients will be randomized 1:1 to fasting (6 h solid food and 2 h clear liquids) or to no fasting requirements. The primary outcome will be a composite of hypotension, hyperglycaemia, hypoglycaemia, and aspiration pneumonia. Secondary outcomes will include patient satisfaction, contrast-induced nephropathy, new intensive care admission, new non-invasive or invasive ventilation requirement post procedure, and 30-day mortality and readmission. Conclusions: This is a pragmatic and clinically relevant randomised trial designed to compare fasting verse no fasting prior to cardiac catheterisation procedures. Routine fasting may not reduce peri-procedural adverse events in this setting.

1 October 2024 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
ABAdam C. Bland
Adam C. Bland
WMWilliam Meere
William Meere
PMPhilopatir Mikhail
Philopatir Mikhail
ECEunice Chuah
Eunice Chuah
EREleanor Redwood
Eleanor Redwood
TFTom J. Ford
Tom J. Ford
BACKGROUND: The 1.5 mm Baby J hydrophilic narrow J-tipped wire is a development of the standard 0.035” 3-mm J-tipped peripheral guidewire, designed to improve efficiency of transradial coronary procedures by safely navigating small caliber radial arteries to the aorta. There is currently a lack of evidence comparing the procedural success and safety of different peripheral guidewires used in transradial cardiac procedures. We compared the efficacy and safety of a narrow J-tipped hydrophilic 0.035” wire (intervention, Radifocus Baby J guidewire; TERUMO Co, Tokyo, Japan) versus a standard fixed-core 0.035” J wire (control). METHODS: Investigator-initiated, blinded, Australian, multicenter randomized trial in patients undergoing clinically indicated coronary angiography or percutaneous coronary intervention. Patients were randomized 1:1 to use either the control guidewire or the intervention guidewire. The primary end point (technical success) was defined as gaining aortic root access with the randomized guidewire. RESULTS: In all, 330 patients were randomized between October 2022 and June 2023 (median age was 69 years, 36% were female, and body mass index was 29 kg/m 2 ). The primary end point was achieved more frequently in the intervention group (96% versus 84%; absolute risk reduction 12% [95% CI, 5.7–18.3]; P <0.001). Women assigned to the control wire experienced a higher failure rate compared with men (31% versus 8% in men; P <0.001). Fluoroscopy time was significantly lower in the Baby J group (median, 344 versus 491 seconds; P =0.024). The main mechanisms of failure using the control wire were radial artery spasm (15/26; 57%) and subclavian tortuosity (5/26; 19.2%). There were no differences in overall procedure times, major adverse cardiovascular events, or vascular complications between guidewires. CONCLUSIONS: A narrow 1.5 mm J-tipped hydrophilic guidewire resulted in greater technical success and reduced fluoroscopy time compared with the standard 3-mm J-tipped nonhydrophilic guidewire. The guidewire is safe and demonstrated key incremental benefits for the transradial approach, particularly in women. REGISTRATION: URL: https://www.anzctr.org.au/ ; Unique identifier: ACTRN12622001557729.

11 December 2017 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
RNRena Ng
Rena Ng
DFDavid Ferreira
David Ferreira
ADAllan Davies
Allan Davies
EHElizabeth Hesketh
Elizabeth Hesketh
BBBruce Bastian
Bruce Bastian
A 15-year-old male with Klinefelter syndrome presented with neutropenic septic shock and multiorgan failure. Bone marrow biopsy demonstrated precursor B-cell acute lymphoblastic leukaemia. AEIOP chemotherapy was initiated on Day 6 of admission (prednisone, vincristine, daunorubicin, pegylated asparaginase, methotrexate, and intrathecal cytarabine). At Day 21, during his induction phase, echocardiography demonstrated new widespread myocardial calcification. On apical four chamber views, there was dense calcification of the left and right ventricular myocardium, the mitral annulus, the interventricular septum, and the interatrial septum (Panel A). Involvement of the papillary muscle was seen on the parasternal short axis view (Panel B). The echocardiographic ejection fraction was visually estimated at 50% (see Supplementary data online, Video S1 ). Computed tomography revealed dense myocardial calcification concentrated around the left ventricle (Panel C). The post contrast cardiac magnetic resonance images demonstrated multifocal areas of delayed enhancement extending from the pericardium to the subendocardium with a small pericardial effusion (Panel D). The left ventricular ejection fraction was measured as 36% with minimal tricuspid and mitral regurgitation (see Supplementary data online, Video S2 ).